Literature DB >> 25260837

The role of pasireotide in the treatment of acromegaly.

Nicholas A Tritos1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25260837     DOI: 10.1016/S2213-8587(14)70175-5

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  1 in total

Review 1.  New therapeutic agents for acromegaly.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2015-11-27       Impact factor: 43.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.